Institute for Wealth Management LLC. Sells 120 Shares of VanEck Biotech ETF (NASDAQ:BBH)

Institute for Wealth Management LLC. trimmed its stake in VanEck Biotech ETF (NASDAQ:BBH) by 1.5% in the fourth quarter, Holdings Channel reports. The firm owned 7,678 shares of the company’s stock after selling 120 shares during the quarter. Institute for Wealth Management LLC.’s holdings in VanEck Biotech ETF were worth $1,269,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Kestra Advisory Services LLC boosted its stake in shares of VanEck Biotech ETF by 16.1% during the 3rd quarter. Kestra Advisory Services LLC now owns 3,061 shares of the company’s stock worth $477,000 after acquiring an additional 424 shares during the period. Anchor Investment Management LLC bought a new position in shares of VanEck Biotech ETF during the 4th quarter worth approximately $26,000. Raymond James Financial Services Advisors Inc. boosted its stake in shares of VanEck Biotech ETF by 34.5% during the 4th quarter. Raymond James Financial Services Advisors Inc. now owns 19,129 shares of the company’s stock worth $3,162,000 after acquiring an additional 4,909 shares during the period. Wealthfront Advisers LLC boosted its stake in shares of VanEck Biotech ETF by 32.8% during the 3rd quarter. Wealthfront Advisers LLC now owns 5,229 shares of the company’s stock worth $814,000 after acquiring an additional 1,292 shares during the period. Finally, Private Advisor Group LLC boosted its stake in VanEck Biotech ETF by 4.7% in the 3rd quarter. Private Advisor Group LLC now owns 1,675 shares of the company’s stock valued at $261,000 after purchasing an additional 75 shares during the period. 32.05% of the stock is currently owned by institutional investors.

VanEck Biotech ETF Stock Performance

BBH opened at $152.36 on Friday. The business has a fifty day simple moving average of $162.68 and a 200 day simple moving average of $159.71. VanEck Biotech ETF has a 1 year low of $142.51 and a 1 year high of $171.04.

VanEck Biotech ETF Profile

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.